Pieris Pharmaceuticals (PIRS) Income Statement (2015 - 2024)
Income Statement report data from Jun 30, 2015 to Sep 30, 2024 for Pieris Pharmaceuticals (PIRS).
Reported currency: USD
| Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||||||||||||||||
Total Revenue | - | - | - | - | 20M (-2.69%) | 20M (+934.02%) | 1.94M (-66.84%) | 5.85M (+8.94%) | 5.37M (+45.14%) | 3.70M (-66.33%) | 11M (+30.21%) | 8.44M (+107.88%) | 4.06M (+23.40%) | 3.29M (-78.95%) | 16M (+731.38%) | 1.88M (-36.05%) | 2.94M (-73.87%) | 11M (-15.16%) | 13M (-23.22%) | 17M (+14.14%) | 15M (+183.86%) | 5.33M (-37.66%) | 8.55M (+74.13%) | 4.91M (-41.20%) | 8.35M (-28.57%) | 12M (+181.69%) | 4.15M (-77.13%) | 18M (+361.83%) | 3.93M (+112.43%) | 1.85M (+38.06%) | 1.34M (-50.92%) | 2.73M (+245.57%) | 790K (-26.17%) | 1.07M (-14.40%) | 1.25M (-41.59%) | 2.14M (+421.95%) | 410K (+156.25%) | 160K |
Gross Profit | - | - | - | - | 20M (-2.69%) | 20M (+934.02%) | 1.94M (-66.84%) | 5.85M (+8.94%) | 5.37M (+45.14%) | 3.70M (-66.33%) | 11M (+30.21%) | 8.44M (+107.88%) | 4.06M (+23.40%) | 3.29M (-78.95%) | 16M (+731.38%) | 1.88M (-36.05%) | 2.94M (-73.87%) | 11M (-15.16%) | 13M (-23.22%) | 17M (+14.14%) | 15M (+183.86%) | 5.33M (-37.66%) | 8.55M (+74.13%) | 4.91M (-41.20%) | 8.35M (-28.57%) | 12M (+181.69%) | 4.15M (-77.13%) | 18M (+361.83%) | 3.93M (+112.43%) | 1.85M (+38.06%) | 1.34M (-50.92%) | 2.73M (+245.57%) | 790K (-26.17%) | 1.07M (-14.40%) | 1.25M (-41.59%) | 2.14M (+421.95%) | 410K (+156.25%) | 160K |
Operating Expenses | ||||||||||||||||||||||||||||||||||||||
Research And Development | 3.18M (+120.83%) | 1.44M (+46.94%) | 980K | -28.55M | 9.60M (-33.01%) | 14M (+6.78%) | 13M (+0.30%) | 13M (-1.55%) | 14M (+13.72%) | 12M (-15.07%) | 14M (-8.40%) | 15M (-18.90%) | 19M (+19.87%) | 16M (-4.59%) | 17M (+55.93%) | 11M (-10.15%) | 12M (+4.32%) | 11M (-11.21%) | 13M (-9.63%) | 14M (+6.89%) | 13M (-1.20%) | 13M (-6.50%) | 14M (+10.00%) | 13M (+14.04%) | 11M (+24.59%) | 9.15M (+15.24%) | 7.94M (+50.66%) | 5.27M (-15.81%) | 6.26M (+15.93%) | 5.40M (+0.75%) | 5.36M (-22.54%) | 6.92M (+49.78%) | 4.62M (+2.67%) | 4.50M (+22.95%) | 3.66M (+24.49%) | 2.94M (+43.41%) | 2.05M (+18.50%) | 1.73M |
Selling General And Administrative | 1.88M (+27.89%) | 1.47M (+88.46%) | 780K | -11.45M | 6.84M (+86.89%) | 3.66M (-8.96%) | 4.02M (+0.75%) | 3.99M (+1.01%) | 3.95M (-3.19%) | 4.08M (-6.85%) | 4.38M (+7.09%) | 4.09M (-0.97%) | 4.13M (-2.82%) | 4.25M (+2.91%) | 4.13M (+12.53%) | 3.67M (-10.92%) | 4.12M (-9.85%) | 4.57M (+4.82%) | 4.36M (-2.68%) | 4.48M (-7.44%) | 4.84M (+15.51%) | 4.19M (-15.01%) | 4.93M (+8.11%) | 4.56M (-4.00%) | 4.75M (-0.63%) | 4.78M (+9.89%) | 4.35M (-31.92%) | 6.39M (+124.21%) | 2.85M (-34.48%) | 4.35M (+9.02%) | 3.99M (+80.54%) | 2.21M (-5.56%) | 2.34M (-1.27%) | 2.37M (+20.30%) | 1.97M (+11.93%) | 1.76M (-21.43%) | 2.24M (+13.71%) | 1.97M |
Operating Expenses | 5.06M (+73.88%) | 2.91M (+65.34%) | 1.76M | -54.90M | 31M (+74.15%) | 18M (+3.09%) | 17M (+0.52%) | 17M (-1.03%) | 18M (+9.42%) | 16M (-13.12%) | 18M (-5.09%) | 19M (-15.73%) | 23M (+15.06%) | 20M (-3.09%) | 21M (+44.79%) | 14M (-10.35%) | 16M (+0.25%) | 16M (-7.13%) | 17M (-7.96%) | 19M (+3.05%) | 18M (+2.79%) | 18M (-8.68%) | 19M (+9.51%) | 18M (+8.73%) | 16M (+15.94%) | 14M (+13.34%) | 12M (+5.40%) | 12M (+27.99%) | 9.11M (-6.47%) | 9.74M (+4.17%) | 9.35M (+2.41%) | 9.13M (+31.18%) | 6.96M (+1.31%) | 6.87M (+22.02%) | 5.63M (+19.79%) | 4.70M (+9.56%) | 4.29M (+16.26%) | 3.69M |
Operating Income | ||||||||||||||||||||||||||||||||||||||
Operating Income | -5.06M (+73.88%) | -2.91M (+65.34%) | -1.76M | 13M | -11.81M | 2.06M | -15.51M (+34.64%) | -11.52M (-5.34%) | -12.17M (-1.30%) | -12.33M (+65.28%) | -7.46M (-32.18%) | -11.00M (-42.14%) | -19.01M (+13.42%) | -16.76M (+231.23%) | -5.06M (-59.23%) | -12.41M (-4.54%) | -13.00M (+179.57%) | -4.65M (+20.47%) | -3.86M (+190.23%) | -1.33M (-54.30%) | -2.91M (-76.21%) | -12.23M (+14.51%) | -10.68M (-15.57%) | -12.65M (+62.18%) | -7.80M (+248.21%) | -2.24M (-72.48%) | -8.14M | 6.49M | -5.18M (-34.35%) | -7.89M (-1.50%) | -8.01M (+25.16%) | -6.40M (+3.56%) | -6.18M (+6.55%) | -5.80M (+32.42%) | -4.38M (+70.43%) | -2.57M (-33.76%) | -3.88M (+9.92%) | -3.53M |
EBITDA | -5.06M (+73.88%) | -2.91M (+65.34%) | -1.76M | 13M (+249.61%) | 3.83M (+35.82%) | 2.82M | -14.91M (+36.29%) | -10.94M (-4.04%) | -11.40M (-2.98%) | -11.75M (+77.76%) | -6.61M (-36.38%) | -10.39M (-43.53%) | -18.40M (+14.00%) | -16.14M (+264.33%) | -4.43M (-62.80%) | -11.91M (-2.70%) | -12.24M (+197.09%) | -4.12M (+17.05%) | -3.52M (+232.08%) | -1.06M (-61.45%) | -2.75M (-77.44%) | -12.19M (+15.87%) | -10.52M (-15.71%) | -12.48M (+62.71%) | -7.67M (+265.24%) | -2.10M (-73.75%) | -8.00M | 6.59M | -5.13M (-34.06%) | -7.78M (-1.64%) | -7.91M (+27.17%) | -6.22M (+2.13%) | -6.09M (+4.82%) | -5.81M (+35.43%) | -4.29M (+72.29%) | -2.49M (-34.47%) | -3.80M (+9.83%) | -3.46M |
Other Income / Expenses | ||||||||||||||||||||||||||||||||||||||
Interest Income | 190K | -90.00K | - | - | - | - | - | - | - | - | - | - | - | 800K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense | -1.24M (+27.84%) | -970.00K (+34.72%) | -720.00K | 4.87M (+785.45%) | 550K (+12.24%) | 490K (+36.11%) | 360K (+2.86%) | 350K (+45.83%) | 240K (+84.62%) | 130K | - | -10.00K | - | - | - | 10K (-83.33%) | 60K (-53.85%) | 130K (-59.38%) | 320K (-15.79%) | 380K (0.00%) | 380K (-15.56%) | 450K (-11.76%) | 510K (+8.51%) | 470K (-6.00%) | 500K (-24.24%) | 660K (+100.00%) | 330K (+120.00%) | 150K | - | - | - | - | - | - | - | -180.00K | - | - |
Net Interest Income | 1.42M (+59.55%) | 890K (+23.61%) | 720K | -4.87M (+785.45%) | -550.00K (+12.24%) | -490.00K (+36.11%) | -360.00K (+2.86%) | -350.00K (+45.83%) | -240.00K (+84.62%) | -130.00K | - | 10K | - | 790K | - | -10.00K (-80.00%) | -50.00K (-61.54%) | -130.00K (-59.38%) | -320.00K (-15.79%) | -380.00K (0.00%) | -380.00K (-15.56%) | -450.00K (-11.76%) | -510.00K (+8.51%) | -470.00K (-6.00%) | -500.00K (-24.24%) | -660.00K (+106.25%) | -320.00K (+113.33%) | -150.00K | - | - | - | - | - | - | - | 180K | - | - |
Other Non Operating Income | -660.00K (+214.29%) | -210.00K (+250.00%) | -60.00K | 20M (+3900.00%) | 510K (-64.08%) | 1.42M (-27.92%) | 1.97M (-35.83%) | 3.07M (+40.18%) | 2.19M (+17.74%) | 1.86M (-21.19%) | 2.36M (+60.54%) | 1.47M (-40.49%) | 2.47M (+436.96%) | 460K (-47.73%) | 880K | -1.83M (+36.57%) | -1.34M (+219.05%) | -420.00K (+600.00%) | -60.00K | 180K | -50.00K | 20K | -170.00K | 330K (-71.30%) | 1.15M (-6.50%) | 1.23M | -900.00K | 1.00M | -1.73M (+25.36%) | -1.38M | 10K (0.00%) | 10K | -20.00K (-77.78%) | -90.00K | 220K (+2100.00%) | 10K | - | - |
Net Income | ||||||||||||||||||||||||||||||||||||||
Income Before Tax | -6.77M (+62.35%) | -4.17M (+64.17%) | -2.54M | 39M | -10.75M | 3.98M | -13.18M (+62.72%) | -8.10M (-16.84%) | -9.74M (-5.80%) | -10.34M (+102.75%) | -5.10M (-46.48%) | -9.53M (-42.38%) | -16.54M (+6.71%) | -15.50M (+271.70%) | -4.17M (-70.72%) | -14.24M (-0.28%) | -14.28M (+188.48%) | -4.95M (+37.50%) | -3.60M (+367.53%) | -770.00K (-70.27%) | -2.59M (-77.98%) | -11.76M (+13.62%) | -10.35M (-12.66%) | -11.85M (+92.68%) | -6.15M (+1657.14%) | -350.00K (-95.98%) | -8.71M | 7.64M | -6.91M (-25.46%) | -9.27M (+16.02%) | -7.99M (+24.84%) | -6.40M (+3.23%) | -6.20M (+5.44%) | -5.88M (+41.35%) | -4.16M (+51.82%) | -2.74M (-29.38%) | -3.88M (+9.92%) | -3.53M |
Income Tax Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -160.00K | - | -150.00K | - | 140K (-6.67%) | 150K | - | - | - | - | - | - | 160K (+300.00%) | 40K | - |
Net Income From Continuing Operations | -6.77M (+62.35%) | -4.17M (+64.17%) | -2.54M | 39M | -10.75M | 3.98M | -13.18M (+62.72%) | -8.10M (-16.84%) | -9.74M (-5.80%) | -10.34M (+102.75%) | -5.10M (-46.48%) | -9.53M (-42.38%) | -16.54M (+6.71%) | -15.50M (+271.70%) | -4.17M (-71.04%) | -14.40M (+0.84%) | -14.28M (+188.48%) | -4.95M (+37.50%) | -3.60M (+367.53%) | -770.00K (-70.27%) | -2.59M (-77.98%) | -11.76M (+13.62%) | -10.35M (-11.39%) | -11.68M (+89.92%) | -6.15M (+2975.00%) | -200.00K (-97.70%) | -8.71M | 7.49M | -7.06M (-30.03%) | -10.09M (+26.28%) | -7.99M (+21.80%) | -6.56M (+5.81%) | -6.20M (+5.44%) | -5.88M (+41.35%) | -4.16M (+43.45%) | -2.90M (-26.02%) | -3.92M (+11.05%) | -3.53M |
Net Income | -6.77M (+62.35%) | -4.17M (+64.17%) | -2.54M | 39M | -10.75M | 3.98M | -13.18M (+62.72%) | -8.10M (-16.84%) | -9.74M (-5.80%) | -10.34M (+102.75%) | -5.10M (-46.48%) | -9.53M (-42.38%) | -16.54M (+6.71%) | -15.50M (+271.70%) | -4.17M (-71.04%) | -14.40M (+0.84%) | -14.28M (+188.48%) | -4.95M (+37.50%) | -3.60M (+367.53%) | -770.00K (-70.27%) | -2.59M (-77.98%) | -11.76M (+13.62%) | -10.35M (-11.39%) | -11.68M (+89.92%) | -6.15M (+2975.00%) | -200.00K (-97.70%) | -8.71M | 7.49M | -7.06M (-30.03%) | -10.09M (+26.28%) | -7.99M (+21.80%) | -6.56M (+5.81%) | -6.20M (+5.44%) | -5.88M (+41.35%) | -4.16M (+43.45%) | -2.90M (-26.02%) | -3.92M (+11.05%) | -3.53M |